BASL Winter Meeting 2016
[Edited 05/11/2016: schedule was updated to latest version]
FRIDAY 2nd of DECEMBER
08:30-10:30 TOPIC 1 : CHOLESTATIC LIVER DISEASE
Moderators : Wim Laleman (KUL), Peter Starkel (UCL)
- Cholestasis : new insights in pathophysiology
Prof. Peter Jansen (Amsterdam & Maastricht, The Netherlands)
- Autoimmune cholangitis & primary sclerosing cholangitis : similar yet different ? A guide for the clinician.
Prof. Cyriel Ponsioen (Amsterdam, The Netherlands)
- Primary Biliary Cholangitis : an update on risk stratification and therapy.
Prof. Henk van Buuren (Rotterdam, The Netherlands)
10:30-11:00 COFFEE BREAK
11:00-12:15 NON-INTERACTIVE DISCUSSION OF CLINICAL CASES
Moderators : Anja Geerts (RUG), Jean Delwaide (ULg)
4-5 cases/10-15 minutes
12:15-12:35 Presentations BASL YOUNG INVESTIGATORS AWARD LAUREATES
Eric Trépo (ULB), Charlotte Debbaut (RUG)
12:35-12:40 MSD Awards 2016
12:40-13:00 Short communications & Results elections new SC 2017-2021
14:00-15:00 TOPIC 2 : BENIGN LIVER TUMORS
Moderators : Sven Francque (UZA), Christophe Moreno (ULB)
- BENIGN LIVER TUMORS: How to diagnose? When biopsy is needed?
Prof. Monia Bali (Brussels, Belgium)
- LIVER ADENOMA: Is pathological classification relevant for the clinician?
Dr Jean-Charles Nault (Paris, France)
15:00-16:30 TOPIC 3 : HEPATITIS C
Moderators : Stephane De Maeght (Jolimont), Jean Pierre Mulkay (CHU St Pierre)
- Resistance Associated Variants (RAVs) : are they clinically relevant ?
Dr. Johannes Vermehren (Frankfurt am Main, Germany)
- What has changed and what is coming in 2017 ?
Prof. Christophe Moreno (ULB, Belgium)
- An update on difficult to treat patients
Dr. Stefan Bourgeois (ZNA, Belgium)
16:30 CONCLUSIONS & FAREWELL
SATURDAY 3rd OF DECEMBER
09:00-09:15 General introduction BASL young BASL in the picture
Yves-Paul Vandewynckel (UZG)
09:15-09:45 New EASL guidelines update/overview: what's new and what's essential
Frederik Nevens (UZ Leuven)
09:45-10:15 Pre-liver TX investigations and (specific) indications, e.g. what to do with Hep C: to treat or not to treat? When is it too early and when is it too late to select a patient
L. Vonghia (UZA).
10:15-10:45 Transplant selection criteria for patients with HCC, role of down-staging, will criteria be expanded in the future?
Hans Van Vlierberghe (UZ Gent)
10:45-11:15 COFFEE BREAK (10u45-11u15)
11:15-12:00 Immune supression and withdrawal of immune supression, the concept of immune tolerance (basic, clinical)
Alberto Sanchez Fueyo (Kings college, London)
12:00-12:30 Liver transplant and alcohol, also ethical considerations
C. Moreno (ULB).
12:30-13:00 Long term follow up of transplant patients, therapeutic complicance
G. Dahlqvist (UCL).
13:00 DEBRIEFING AND FAREWELL.
50 euro by banking and on-site
NON-MEMBERS IN TRAINING
15 euro by banking and on-site
BANK ACCOUNT NUMBER
IBAN BE69 0013 4462 1878